Unaudited Financial Results and Limited Review Report for the Quarter Ended 30th September 2025
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amrutanjan Health Care Limited has submitted its unaudited standalone/consolidated financial results along with the auditor's limited review report for the quarter ended 30 September 2025. This is a routine quarterly compliance filing required under SEBI's Listing Obligations and Disclosure Requirements (LODR). The limited review report indicates the figures have not been subjected to a full statutory audit but have been reviewed by the statutory auditors. Specific revenue, profit, and margin figures were not provided in the filing headline and would need to be referenced from the detailed results document. The filing is timely and reflects standard quarterly financial disclosure practices.
Routine quarterly results submission — investors should review the detailed numbers for revenue trends, margin movement, and profit growth compared to the previous quarter and year-ago period. No immediate material corporate action is signalled from the filing type itself.